Grupo Gallego De Investigaciones Oncológicas[Corporate Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Gemcitabine and capecitabine as third- or later-line therapy for refractory advanced colorectal cancer: a retrospective study.

Salgado M, Reboredo M, Mendez JC, Quintero G, Pellón ML, Romero C, Jorge M, Montes AF, Valladares-Ayerbes M, Ramos M, Varela S, Alonso MÁ; Grupo Gallego De Investigaciones Oncológicas. Salgado M, et al. Anticancer Res. 2013 Sep;33(9):4089-96. Anticancer Res. 2013. PMID: 24023354

Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer.

Grande C, Quintero G, Candamio S, París Bouzas L, Villanueva MJ, Campos B, Gallardo E, Alvarez E, Casal J, Mel JR; Grupo Gallego de Investigaciones Oncológicas (GGIO). Grande C, et al. J Geriatr Oncol. 2013 Apr;4(2):114-21. doi: 10.1016/j.jgo.2013.01.001. Epub 2013 Feb 16. J Geriatr Oncol. 2013. PMID: 24071536 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters